跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIMERVAX EMULSION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BIMERVAX EMULSION INYECTABLE
Approved
STANDARD
BIMERVAX EMULSION INYECTABLE
Hipra Human Health S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 5, 2023
Approval ID
7164785270594445
Company
Hipra Human Health S.L.
Type
Standard
Approval Details
Approval Id
7164785270594445
Drug Cima Aemps Name
BIMERVAX EMULSION INYECTABLE
Register Number
1221709001
Holder Company Name
Hipra Human Health S.L.
Marketing Company Name
Hipra Human Health S.L.
Holder Company Detail Path
/organization/hipra-human-health-sociedad-limitada
Marketing Company Detail Path
/organization/hipra-human-health-sociedad-limitada
Authorization Date
2023-04-05
Dosage Form
EMULSIÓN INYECTABLE
Dose
0,5 ML
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Hipra Human Health S.L.
Company Detail Path
/organization/hipra-human-health-sociedad-limitada
Company Information
Pharmaceutical Company Name
HIPRA HUMAN HEALTH SOCIEDAD LIMITADA.
Country Name
Spain
City Name
amer,girona,country_es
Address
AVENIDA SELVA 135
Active Ingredients
VACUNA DE PROTEINA RECOMBINANTE DE HETERODIMEROS DEL DOMINIO DE UNION AL RECEPTOR (RBD) DEL VIRUS SARS-COV-2 ADYUVADA (HIPRA)
40 µg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 5, 2023
Approval ID
7164785270594445
Type
Standard
Back to CIMA-AEMPS Approvals